Participants who took tirzepatide (Zepbound) dropped an average of 50 pounds over 72 weeks. Those who took semaglutide ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects on ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...

Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.

Ozempic and other GLP-1 drugs have easily become one of the hottest topics in healthcare, especially because they have a ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

If you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Khalid bin Abdulaziz Al-Falih and several officials, along with representatives from Novo Nordisk and Lifera. Semaglutide GLP-1 treatments are the global market-leading therapeutics for weight ...

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business ... up any revenue loss from semaglutide. Revenue grew 95% y/y to $481.1 million, ahead of Wall ...

With the glucagon-like peptide-1 receptor agonists ... a compounding pharmacy sued by Eli Lilly on 1 April, detailing safety shortcomings. Novo Nordisk is treading familiar ground with its semaglutide ...